Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.21.2
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Gain (Loss) on Sale of Derivatives $ 204,000 $ 198,000    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Secured debt $ 21,190,000   21,190,000     $ 50,000,000
Initial measurement of fair value     599,000   $ 797,000  
Gain (Loss) on Sale of Derivatives     $ 198,000      
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Secured debt           $ 20,000,000